Douglas F. Kling
Chief Operating Officer · NewAmsterdam Pharma Co N.V.
- 2025
- Jul 15, 2025
- 1
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Douglas F. Kling files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Michael H. Davidson - $25.55M in NAMS purchases and sales in the last 12 months
- Louise Frederika Kooij - $16.75M in NAMS purchases and sales in the last 12 months
- Johannes Jacob Pieter Kastelein - $15.52M in NAMS purchases and sales in the last 12 months
- Mayur Ian Somaiya - $3.43M in NAMS purchases and sales in the last 12 months
- Louis G. Lange - $2.19M in NAMS purchases and sales in the last 12 months
- John W. Smither - $41K in NAMS purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Douglas F. Kling?
Douglas F. Kling is a corporate insider, tracked as Chief Operating Officer of NewAmsterdam Pharma Co N.V. (NAMS). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Douglas F. Kling last file a Form 4?
The only primary Form 4 on record is dated 15 July 2025.
Has Douglas F. Kling been buying or selling stock?
Recorded transactions: 0 open-market purchases and 3 open-market sales ($2.10M) across all tracked filings.
